SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-09
👔
IONIS PHARMACEUTICALS INC
@IONS_InsiderForm 4 Filing: BENNETT C FRANK Sells $1.7M of $IONS
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
IONIS PHARMACEUTICALS INC
Ticker: $IONS
Transaction Value
$1.7M
Price/Share: $49.09
transaction date
2026-07-07
Shares: 35,536
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, BENNETT C FRANK, holds the title of EVP, Chief Scientific Officer at IONIS PHARMACEUTICALS INC.
On 2026-07-07, the insider transacted 35,536 shares.The shares were transacted at a weighted average price of $49.09 per share, resulting in a total market-relevant value of $1.7M.
Executive Summary Summary
BENNETT C FRANK (EVP, Chief Scientific Officer) sold $1.7M of $IONS
Post-Transaction Position: 0 shares
SEC Accession No: 0000874015-26-000239 (CIK: 1073387)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.